Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
Published evidence in the literature, regulatory status, and relative costs of colchicine and nonsteroidal anti-inflammatory drugs (NSAIDs) for prophylaxis of gouty flares during early urate-lowering therapy are reviewed.
Department of Pharmacy Services, University Healthcare, Salt Lake City, Utah, USA. Dave.peterson@hsc.utah.edu
David M
DM
Peterson
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use*; D003078:Colchicine / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D006073:Gout / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D006074:Gout Suppressants / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D017410:Practice Guidelines as Topic; D014527:Uric Acid / Q000097:blood
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D014527:Uric Acid; D003078:Colchicine